CH179973A - Process for the preparation of a mixture of isomeric octahydrofollicle hormones of the formula C18H30O2. - Google Patents

Process for the preparation of a mixture of isomeric octahydrofollicle hormones of the formula C18H30O2.

Info

Publication number
CH179973A
CH179973A CH179973DA CH179973A CH 179973 A CH179973 A CH 179973A CH 179973D A CH179973D A CH 179973DA CH 179973 A CH179973 A CH 179973A
Authority
CH
Switzerland
Prior art keywords
formula
octahydrofollicle
isomeric
hormones
mixture
Prior art date
Application number
Other languages
German (de)
Inventor
Schering-Kahlbaum A G
Original Assignee
Schering Kahlbaum Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Kahlbaum Ag filed Critical Schering Kahlbaum Ag
Publication of CH179973A publication Critical patent/CH179973A/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Description

  

  Verfahren zur Darstellung eines Gemisches     isomerer        Octahydrofollikelhormone     der Formel     CisHso02.       Gegenstand vorliegenden Patentes ist  ein Verfahren zur Herstellung eines Gemi  sches     isomerer        Octahydrofollikelhormone    der  Formel     C1.H3,02,    das dadurch gekennzeich  net ist, dass man das Reduktionsprodukt der  Formel     C"H"02    vom Schmelzpunkt 1,68 bis  <B>170'</B> C des     Follikelhormons    in Anwesenheit  eines Katalysators, der die Hydrierung des       Benzolkernes    begünstigt, mit einem hydrie  renden Mittel bis zur Bildung des Produktes       C"H3@0,

      behandelt.  



  Das neue Produkt soll als Arzneimittel  zur 'Behebung von Ausfallserscheinungen,  wie sie am männlichen Organismus bei Man  gel an männlichem Keimdrüsenhormon beob  achtet werden, Verwendung finden.    <I>Beispiel:</I>    1 g     Dihydrofollikelhormon        618H2402    vom       Schmelzpunkt        16$    bis<B>170'</B> werden in  150 cm' reinem Eisessig gelöst und die Lö  sung nach Zugabe vom 200 mg     Platinogyd-          katalysator    nach     Adams-Shriner    bei Zim  mertemperatur in einer Wasserstoffatmo-         sphäre    geschüttelt.

   Nach beendeter Wasser  stoffaufnahme wird die vom Katalysator be  freite     Reaktionslösung    im     Vaccum    zur  Trockne abgedampft. Es     hinterbleibt    als  Rückstand ein helles konsistentes Harz mit  einem physiologischen Wirkungswert von  zirka 8     mg/KE.  



  Process for the preparation of a mixture of isomeric octahydrofollicle hormones of the formula CisHso02. The present patent relates to a process for the preparation of a mixture of isomeric octahydrofollicle hormones of the formula C1.H3,02, which is characterized in that the reduction product of the formula C "H" 02 has a melting point of 1.68 to 170 ' / B> C of the follicle hormone in the presence of a catalyst that favors the hydrogenation of the benzene nucleus, with a hydrogenating agent until the product C "H3 @ 0 is formed,

      treated.



  The new product is intended to be used as a medicinal product for 'remedying failure symptoms such as those observed in the male organism when there is a lack of male gonadal hormone. <I> Example: </I> 1 g of dihydrofollicle hormone 618H2402 with a melting point of 16 $ to <B> 170 '</B> is dissolved in 150 cm' of pure glacial acetic acid and the solution after adding 200 mg of platinum hydrate catalyst according to Adams- Shriner shaken in a hydrogen atmosphere at room temperature.

   After the uptake of hydrogen has ended, the reaction solution freed from the catalyst is evaporated to dryness in a vacuum. A pale, consistent resin with a physiological action value of approximately 8 mg / CU remains as the residue.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung eines Gemi sches isomerer Octahydrofollikelhormone der Formel C"H"0@2, dadurch gekennzeichnet, dass man das Reduktionsprodukt des Follikel hormons der Formel C1sH240'2 vom Schmelz punkt 16,8 bis 170 o C in Anwesenheit eines Katalysators, der die Hydrierung des Ben- zolkerns begünstigt, mit einem hydrieren den Mittel bis zur Bildung des Produktes C18H30O2 behandelt. PATENT CLAIM: A process for the preparation of a mixture of isomeric octahydrofollicle hormones of the formula C "H" 0 @ 2, characterized in that the reduction product of the follicle hormone of the formula C1sH240'2 has a melting point of 16.8 to 170 o C in the presence of a catalyst, which favors the hydrogenation of the benzene nucleus, treated with a hydrogenating agent until the product C18H30O2 is formed. Das neue Produkt stellt ein helles kon sistentes Harz mit einem physiologischen Wirkungswert. von zirka 8 mg/gE dar. The new product is a light-colored, consistent resin with a physiological effect value. of about 8 mg / gU.
CH179973D 1932-10-27 1933-10-10 Process for the preparation of a mixture of isomeric octahydrofollicle hormones of the formula C18H30O2. CH179973A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE179973X 1932-10-27
CH173197T 1933-10-10

Publications (1)

Publication Number Publication Date
CH179973A true CH179973A (en) 1935-09-30

Family

ID=25719329

Family Applications (1)

Application Number Title Priority Date Filing Date
CH179973D CH179973A (en) 1932-10-27 1933-10-10 Process for the preparation of a mixture of isomeric octahydrofollicle hormones of the formula C18H30O2.

Country Status (1)

Country Link
CH (1) CH179973A (en)

Similar Documents

Publication Publication Date Title
DE1290535B (en) Process for the separation and recovery of rhodium from hydroformylation products
CH179973A (en) Process for the preparation of a mixture of isomeric octahydrofollicle hormones of the formula C18H30O2.
CH179974A (en) Process for the preparation of a mixture of isomeric octahydrofollicle hormones of the formula C18H30O2.
AT142359B (en) Process for the production of hydrogenation products of the follicular hormones obtained from animal or vegetable material or synthetically.
AT160612B (en) Process for the preparation of androstanol- (3) -one- (17) or of androstandiol- (3.17) or their stereoisomers.
DE918748C (en) Process for the preparation of oxoacetylamines (17-acetyl-aminoketones) of the cyclopentanopolyhydrophenanthrene series
AT119208B (en) Process for the simultaneous extraction and separation of the lipoid and water-soluble active substances from male and female gonads.
DE548821C (en) Process for the production of water-soluble, physiologically active substances containing preparations from germ glands or other substances containing sex hormones by saponification of the raw material or extracts made therefrom
DE697757C (en) Process for the representation of diketones
AT101671B (en) Process for the preparation of carboxylic acid esters of polyhydric, halogenated alcohols.
CH122241A (en) Process for the preparation of Bz-3-methylbenzanthrone.
CH122063A (en) Process for the preparation of 2,6 dimethylanthracene.
CH184419A (en) Process for the preparation of a mixture of stereoisomeric dihydrofollicle hormones of the formula C18H24O2.
CH122519A (en) Process for the preparation of an aralkylamine.
CH119360A (en) Process for the preparation of a hydrogenated quinone derivative.
CH104482A (en) Process for the preparation of a new arsenic compound.
CH228433A (en) Process for the preparation of 2,4-dibromo-androstanol acetate- (17) -one- (3).
CH189808A (en) Process for the production of a polynuclear ring ketone.
CH172508A (en) Procedure for purifying the gonad hormones.
CH212336A (en) Method for the preparation of a 4,5-unsaturated 3-ketone of the sex hormone series.
CH232534A (en) Process for the preparation of pregnendiol- (3,21) -one- (20).
CH212115A (en) Process for the preparation of a pregnen-3-ol-20-one derivative.
CH184474A (en) Process for the preparation of a heterocyclic compound.
CH188242A (en) Process for the production of a polynuclear ring ketone.
CH196648A (en) Process for the preparation of 3-acetyl-17-benzoyl-trans-androstandiol-3,17.